Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advances in Treatment of Psychiatric Disorders in Patients with HIV.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same author

Non-invasive Vagal Nerve Stimulation Decreases the Need for Rescue Medication for Nausea Exacerbation in Patients with Chronic Nausea and Vomiting.

Digestive diseases and sciences·2025
Same author

Postural orthostatic tachycardia syndrome and other common autonomic disorders are not functional neurologic disorders.

Frontiers in neurology·2024
Same author

Harnessing complexity: Nonlinear optical phenomena in L-shapes, nanocrescents, and split-ring resonators.

The Journal of chemical physics·2024
Same author

Long COVID Is Not a Functional Neurologic Disorder.

Journal of personalized medicine·2024
Same author

Interplay between gain and loss in arrays of nonlinear plasmonic nanoparticles: toward parametric downconversion and amplification.

Optics letters·2024
Same journal

Joint hypermobility, anxiety and psychosomatics: two and a half decades of progress toward a new phenotype.

Advances in psychosomatic medicine·2015
Same journal

Huntington's disease: looking beyond the movement disorder.

Advances in psychosomatic medicine·2015
Same journal

Psychodermatology.

Advances in psychosomatic medicine·2015
Same journal

Coping with losses, grief, and mourning in prostate cancer.

Advances in psychosomatic medicine·2015
Same journal

Telomeres, early-life stress and mental illness.

Advances in psychosomatic medicine·2015
Same journal

Fibromyalgia and chronic fatigue syndrome: management issues.

Advances in psychosomatic medicine·2015
See all related articles

Related Experiment Video

Updated: Jun 2, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

Optimizing treatment with opioids and beyond.

Michael R Clark, Glenn J Treisman

    Advances in Psychosomatic Medicine
    |April 22, 2011
    PubMed
    Summary
    This summary is machine-generated.

    Treating chronic pain and substance use disorders together requires integrated care. A comprehensive evaluation is key to developing effective, individualized treatment plans for better patient outcomes.

    More Related Videos

    Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
    07:23

    Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

    Published on: July 29, 2014

    Related Experiment Videos

    Last Updated: Jun 2, 2026

    Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
    09:29

    Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

    Published on: August 4, 2022

    Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
    07:23

    Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

    Published on: July 29, 2014

    Area of Science:

    • Pain Management
    • Addiction Medicine
    • Integrated Care

    Background:

    • Co-occurring chronic pain and substance use disorders (SUDs) present complex challenges for healthcare.
    • Current treatment models for either condition alone are often inadequate for patients with both.
    • Opioid therapy for chronic pain in SUD patients raises concerns about efficacy and physician expertise.

    Purpose of the Study:

    • To highlight the need for new treatment paradigms for patients with co-occurring chronic pain and SUDs.
    • To emphasize the limitations of traditional, separate treatment approaches.
    • To advocate for a more integrated and comprehensive approach to care.

    Main Methods:

    • The study reviews the challenges in treating patients with comorbid chronic pain and SUDs.
    • It discusses the inadequacy of current treatment programs.
    • It proposes a new approach centered on comprehensive patient evaluation.

    Main Results:

    • Separate treatments for chronic pain or SUDs negatively impact the management of the other condition.
    • Physicians often lack the knowledge to safely and effectively manage opioid therapy in these patients.
    • Patients express concerns regarding the risks associated with current treatment strategies.

    Conclusions:

    • Integrated treatment programs are essential for effectively managing patients with both chronic pain and SUDs.
    • A thorough evaluation of all contributing factors (medical, behavioral, psychosocial) is the foundation for effective therapy.
    • Intensified, individualized care is necessary to achieve functional rehabilitation goals.